Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harlan S. Robins currently holds 1,405,898 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harlan S. Robins has been a net seller of ADPT stock. They have purchased $0 and sold $43.5M worth of shares.
Harlan S. Robins's most recent insider trade was on Jun 16, 2026, when they sold 6,160 shares at $18.01 per share.
Harlan S. Robins serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 229 insider transactions totaling $43.5M over their tenure at the company.
Harlan S. Robins holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Harlan S. Robins has shown a selling trading pattern, with $0 in total purchases and $43.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Harlan S. Robins was on Jun 15, 2026, when they sold $1.7M worth of ADPT shares. This transaction involved 100,000 shares at $17.37 per share.
Harlan S. Robins currently owns 1,405,898 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harlan S. Robins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harlan S. Robins has 229 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Harlan S. Robins and 40,000+ other insiders.